METHODS OF QUANTIFYING FRATAXIN AND FRATAXIN FUSION PROTEINS

The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g, a tissue sample, by using mass spectrometry.

Saved in:
Bibliographic Details
Main Authors Xu, Xin, Bettoun, Joan David, Wagner, Erik Johan, Wang, Amy Qiu, Mess, Jean-Nicholas
Format Patent
LanguageEnglish
Published 01.09.2022
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g, a tissue sample, by using mass spectrometry.
Bibliography:Application Number: US202017631414